RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)
Clinical trial NCT07492316 · RECRUITING
Trial details
- NCT number
- NCT07492316
- Sponsor
- University of Florida
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-24
- Primary completion
- 2030-09-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.